Monique Bos

Monique Bos serves as a Researcher in the Department of Medical Oncology at Erasmus MC, Rotterdam, specializing in breast cancer outcomes for adolescent and young adult (AYA) populations. Her work integrates national consortia including the NABON-COVID-19 Consortium and Dutch Breast Cancer Research Group (BOOG), driving population-level studies on cancer care delivery and survivorship.

Her research portfolio centers on quality-of-life metrics in AYA cancer survivors, metastatic breast cancer therapeutics, and patient-reported outcome systems. Key investigations include longitudinal analyses of breast cancer survivorship, emergency care pathway optimization, and neuro-oncology outcomes through the SURVAYA study. Methodologically, she leverages registry data, multicenter trials, and mixed-methods approaches to address gaps in AYA oncology care.

Recent publications demonstrate a cohesive trajectory toward patient-centered implementation science, with emphasis on radiotherapy accessibility, metastatic treatment innovations, and emergency care navigation. Her work consistently employs Dutch population registries to generate actionable insights for clinical oncology practice while maintaining focus on vulnerable AYA cohorts.

Collaborative networks form the backbone of Dr. Bos's research, evidenced by leadership roles in BOOG trials and NABON-COVID-19 initiatives. These partnerships facilitate cross-institutional data sharing and protocol standardization across the Netherlands' oncology research ecosystem.